Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies. | Front Immunol | 2022 | 36248810 | PubTator, text mining | PubMed |
| GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis. | Front Endocrinol (Lausanne) | 2022 | 36246907 | PubTator, text mining | PubMed |
| Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinoma. | Front Genet | 2022 | 36246607 | PubTator, text mining | PubMed |
| Enhanced radiation-induced immunogenic cell death activates chimeric antigen receptor T cells by targeting CD39 against glioblastoma. | Cell Death Dis | 2022 | 36245000 | PubTator, text mining | PubMed |
| Identification and characterization of blocking nanobodies against human CD70. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 36239354 | PubTator, text mining | PubMed |
| Recent advances in CAR-T cells therapy for colorectal cancer. | Front Immunol | 2022 | 36238297 | PubTator, text mining | PubMed |
| A recurrent inflammatory myofibroblastic tumor patient with two novel ALK fusions: a case report. | Transl Cancer Res | 2022 | 36237256 | PubTator, text mining | PubMed |
| Mendelian Randomization Studies of Lifestyle-Related Risk Factors for Osteoarthritis: A PRISMA Review and Meta-Analysis. | Int J Mol Sci | 2022 | 36233208 | PubTator, text mining | PubMed |
| Therapeutic Advances in Immunotherapies for Hematological Malignancies. | Int J Mol Sci | 2022 | 36232824 | PubTator, text mining | PubMed |
| The Extracellular Matrix and Neuroblastoma Cell Communication-A Complex Interplay and Its Therapeutic Implications. | Cells | 2022 | 36231134 | PubTator, text mining | PubMed |
| Allosteric Antagonism of the Pregnane X Receptor (PXR): Current-State-of-the-Art and Prediction of Novel Allosteric Sites. | Cells | 2022 | 36230936 | PubTator, text mining | PubMed |
| Metabolic Imaging in B-Cell Lymphomas during CAR-T Cell Therapy. | Cancers (Basel) | 2022 | 36230629 | PubTator, text mining | PubMed |
| HIV-Specific CAR T Cells with CD28 or 4-1BB Signaling Domains Are Phenotypically and Functionally Distinct and Effective at Suppressing HIV and Simian Immunodeficiency Virus. | Immunohorizons | 2022 | 36220186 | PubTator, text mining | PubMed |
| Cysteinyl-tRNA Synthetase 1 Promotes Ferroptosis-Induced Cell Death via Regulating GPX4 Expression. | J Oncol | 2022 | 36213827 | PubTator, text mining | PubMed |
| The roles of small extracellular vesicles as prognostic biomarkers and treatment approaches in triple-negative breast cancer. | Front Oncol | 2022 | 36212432 | PubTator, text mining | PubMed |
| Intracellular radar: Understanding γδ T cell immune surveillance and implications for clinical strategies in oncology. | Front Oncol | 2022 | 36212425 | PubTator, text mining | PubMed |
| Inflammatory Myofibroblastic Tumor of the Hilar Bile Duct: A Case Report and Literature Review. | Front Surg | 2022 | 36211291 | PubTator, text mining | PubMed |
| Stem cell-based multi-tissue platforms to model human autoimmune diabetes. | Mol Metab | 2022 | 36209784 | PubTator, text mining | PubMed |
| The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy. | J Hematol Oncol | 2022 | 36209102 | PubTator, text mining | PubMed |
| Delivering genes with human immunodeficiency virus-derived vehicles: still state-of-the-art after 25 years. | J Biomed Sci | 2022 | 36209077 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=54